Silicon Labs (SLAB) Insider: 1,800-Share Option Exercise and Sale Reported

Rhea-AI Filing Summary

Brandon Tolany, Senior Vice President Worldwide Sales & Marketing of Silicon Laboratories Inc. (SLAB), reported insider transactions dated 08/29/2025. The filing shows the exercise of a non-qualified stock option with a $43.82 exercise price that resulted in acquisition of 1,800 common shares, and a contemporaneous disposition of 1,800 common shares sold at $133.57. After the reported non-derivative transactions the filing lists beneficial ownership amounts of 64,128 and 62,328 shares following each reported non-derivative line, and Table II reports 6,200 derivative securities beneficially owned following the option transactions. The form is filed individually and signed on behalf of the reporting person.

Positive

• Transparent disclosure of option exercise and share sale with transaction prices and post-transaction ownership counts
• Form filed individually and includes signature and reporting person role (Sr VP WW Sales & Marketing)

Negative

• Sale of 1,800 shares at $133.57 reduced reported non-derivative holdings as shown in the filing
• No additional context provided on purpose of sale or use of proceeds in the filing

Insights

Financial Analyst

TL;DR: Officer exercised options and sold an equal number of shares on 08/29/2025; transactions appear routine and non-dilutive to current shareholders.

The filing documents a non-qualified option exercise at an exercise price of $43.82 for 1,800 shares and a same-day sale of 1,800 shares at $133.57. Reported beneficial ownership figures are provided on separate lines: 64,128 and 62,328 shares after the non-derivative transactions, and 6,200 derivative securities outstanding following the option activity. These are factual disclosures of personal transactions by an officer and do not include company forecasts, material corporate events, or changes to capital structure beyond the individual exercises and sale.

Corporate Governance Expert

TL;DR: Disclosure meets Section 16 reporting requirements for an officer; shows option exercise and sale with detailed post-transaction ownership figures.

The Form 4 identifies the reporting person as an officer (Sr VP WW Sales & Marketing) and indicates the form was filed by one reporting person. It lists transaction codes and prices, including an exercise-related acquisition and a sale at market, and provides resulting beneficial ownership counts. The filing includes a signature date and the required instructional remarks, consistent with routine insider reporting practices under the Exchange Act.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tolany Brandon

(Last) (First) (Middle)

400 WEST CESAR CHAVEZ STREET

(Street)

AUSTIN TX 78701

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SILICON LABORATORIES INC. [ SLAB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Sr VP WW Sales & Marketing

3. Date of Earliest Transaction (Month/Day/Year)
08/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.0001 par value	08/29/2025		M		1,800	A	$43.82	64,128	D
Common Stock, $0.0001 par value	08/29/2025		S		1,800	D	$133.57	62,328	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$43.82	08/29/2025		M			1,800	01/28/2020	01/28/2026	Common Stock, $0.0001 par value	1,800	(1)	6,200	D

Explanation of Responses:

1. Not applicable per instruction 4(c)(iii).

Remarks:

	Saie-Yau Hui for Brandon Tolany	09/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did SLAB officer Brandon Tolany report on the Form 4?

The filing reports a non-qualified option exercise acquiring 1,800 shares at an exercise price of $43.82 and a sale of 1,800 common shares at $133.57, both dated 08/29/2025.

How many shares does Brandon Tolany beneficially own after the reported transactions?

The filing shows post-transaction beneficial ownership figures of 64,128 and 62,328 shares on the non-derivative lines and 6,200 derivative securities beneficially owned following the option transactions.

What was the exercise price and sale price reported on the Form 4 for SLAB?

The exercise (option) price reported is $43.82; the reported sale price for the disposed shares is $133.57.

What is Brandon Tolany's role at Silicon Laboratories as stated on the Form 4?

The Form 4 identifies Brandon Tolany as an Officer, specifically Senior Vice President Worldwide Sales & Marketing.

When was the Form 4 transaction dated and when was the form signed?

The transactions are dated 08/29/2025 and the form bears a signature date of 09/02/2025.